# Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions

> **NCT00077324** · — · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 1000 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **GENETIC:** proteomic profiling
- **OTHER:** surface-enhanced laser desorption/ionization-time of flight mass spectrometry
- **PROCEDURE:** biopsy
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT00077324
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2016-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00077324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00077324, "Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00077324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*